ctrl K

Price Alert

Reviva Pharmaceuticals I... (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.35

-0.41 (-54.17%)

At close: Jun 26, 2025, 3:59 PM

Reviva Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.48M	23.37M	18.52M	29.69M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	819.72K	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	666.43K	332.93K	403.82K	1.72M
Total Current Assets	14.68M	23.7M	18.92M	31.4M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	819.72K	n/a	n/a	n/a
Total Assets	15.5M	23.7M	18.92M	31.4M
Account Payables	6.28M	3.85M	3.52M	509.58K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	458.15K	n/a	n/a	n/a
Other Current Liabilities	635.59K	400.49K	2.52M	1.84M
Total Current Liabilities	14.6M	17.18M	6.04M	2.34M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	89.01K	806.65K	567.44K	372.73K
Total Long-Term Liabilities	89.01K	806.65K	567.44K	372.73K
Total Liabilities	14.69M	17.98M	6.61M	2.72M
Total Debt	458.15K	n/a	n/a	n/a
Common Stock	4.66K	2.79K	2.04K	1.44K
Retained Earnings	-164.27M	-134.35M	-91.17M	-66.83M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	812.57K	5.72M	12.32M	28.69M
Total Investments	n/a	n/a	n/a	n/a